Urges shareholders to vote “FOR” Matthews’ three director nominees on the WHITE proxy cardPITTSBURGH, Jan. 10, 2025 (GLOBE NEWSWIRE) -- (NASDAQ GSM: MATW) (“Matthews” or the “Company”) today ...
According to the latest study from BCC Research, "Chronic Disease Management: Therapeutics, Device Technologies, and Global Markets," is projected to grow from $726.3 billion in 2024 to $1.1 trillion ...